|
Luana Pesco Koplowitz, Chief Medical and Scientific Officer, received her MD from Rutgers Medical School and her PhD from Rutgers College of Pharmacy and Columbia Pacific University. She completed her training in Clinical Pharmacology at the University of Miami School of Medicine. She is adjunct Professor of Medicine, Department of Internal Medicine at the Medical Center of Delaware and is also adjunct faculty at the University of Miami Medical School, Department of Internal Medicine, Division of Clinical Pharmacology. She is a fellow of the American College of Clinical Pharmacology and the Faculty of Pharmaceutical Medicine in the United Kingdom. Dr. Pesco Koplowitz is President & Chief Medical and Scientific Officer of DUCK FLATS Pharma, LLC, a biopharmaceutical consulting and contract company. Previously, she was Chief Medical & Scientific Officer of Research Assist, Inc. She also held the position of Global Group Director of Clinical Pharmacology and US Nonclinical Development for the Janssen Research Foundation of Johnson & Johnson. She has worked at Knoll Pharmaceuticals, Fujisawa Pharmaceutical Company, the Squibb Institute for Medical Research (now Bristol-Myers Squibb) and Key Pharmaceuticals. Dr. Pesco Koplowitz is a member of numerous medical and clinical pharmacology organizations and committees, most recently being asked to serve on the FDA/PhRMA QT Working Group Committee. Dr. Pesco Koplowitz has been responsible for numerous successful INDs and NDAs during her 22-year career and holds several use patents in the treatment of various diseases. She has worked in multiple therapeutic areas, and has personal interests in the areas of overall drug development, PK/PD modeling and drug-drug interactions, receptor-binding modeling and special population clinical trials, especially pediatric, elderly and critical-care patients. She is author or co-author on over 30 publications. | 